TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive NCI Director Says Research Budget Cuts Result in Untold “Missed Opportunities,” Provides List of Program Reductions. March 9, 2007
